Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Technology Showcase event in Precision Medicine and Digital Health at the Said Business School brought together prominent scientists, business leaders and healthcare professionals in this field, celebrated new technologies and research initiatives developed in and around Oxford, and explored their commercial potential.

Some of the latest breakthroughs in precision medicine and digital health that are transforming patient care – many of them developed in Oxford – have been in the spotlight at an event held on Tuesday (27 June).

The Oxford Technology Showcase event in Precision Medicine and Digital Health at the Said Business School brought together prominent scientists, business leaders and healthcare professionals in this field, celebrated new technologies and research initiatives developed in and around Oxford, and explored their commercial potential.

 

The event was presented through a partnership of NIHR Oxford Biomedical Research Centre (BRC), Oxford University Innovation, the University of Oxford Medical Sciences Division, the Oxford Academic Health Science Centre (AHSC) and the Oxford Academic Health Science Network (AHSN). The showcase is also sponsored by the innovative product design, development and technology consultancy, Triteq.

Read more.....

Similar stories

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.

Anant Parekh to deliver The Physiological Society's Annual Review Prize Lecture

The Annual Review Prize Lecture is The Physiological Society's most prestigious lecture.

Department of Paediatrics celebrates 50-year anniversary

After being established in 1972, the Department of Paediatrics' contributions have spanned teaching, innovation, and research. The department also builds upon a longer lineage in Oxford that has impacted child health.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from UK research institutions.